Union Bancaire Privee UBP SA Takes $6.51 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Union Bancaire Privee UBP SA purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 12,757 shares of the medical equipment provider’s stock, valued at approximately $6,509,000.

A number of other large investors have also bought and sold shares of ISRG. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the last quarter. LVW Advisors LLC grew its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the period. Hazlett Burt & Watson Inc. lifted its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. grew its position in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,453 shares of company stock valued at $22,059,506 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $584.05 on Monday. The company has a fifty day moving average of $547.16 and a 200 day moving average of $504.78. The company has a market capitalization of $208.03 billion, a P/E ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Truist Financial upped their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.